Dr. Christopher J. Mancuso, MD
Sports Medicine (Sports Medicine (Orthopaedic Surgery) Physician)
- Medicare participating
At a glance
- Medical school
- Jefferson Medical College of Thomas Jefferson University (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 820
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: Jefferson Medical College of Thomas Jefferson University
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Sports Medicine (Orthopaedic Surgery) Physician primary
PA license MD059819L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Lukes Hospital Bethlehem, PA
- Reading Hospital West Reading, PA
- Surgical Institute of Reading Wyomissing, PA
Medical groups
- Orthopaedic Associates of Reading LTD (27 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 820
- Services billed
- 5,712
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 3,071 | 437 |
| Aspiration and/or injection of fluid from large joint | 585 | 415 |
| Established patient office or other outpatient visit, 20-29 minutes | 580 | 395 |
| X-ray of shoulder, minimum of 2 views | 300 | 211 |
| New patient office or other outpatient visit, 30-44 minutes | 172 | 172 |
| Established patient office or other outpatient visit, 30-39 minutes | 163 | 142 |
| X-ray of knee, 3 views | 111 | 93 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 104 | 12 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 40 | 40 |
| Mri scan of lower spinal canal without contrast | 35 | 35 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Meloxicam Other prescribers in West Reading, PA | 219 |
| Celecoxib Other prescribers in West Reading, PA | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,580 in research payments for these studies, mostly to the institutions running them.
- A phase 2B, randomized, double-blind, parallel group, placebo controll
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.